Supports research and education to advance the diagnosis, understanding, and treatment of Primary Immunodeficiency through translational science and global physician collaboration.
Funder: Jeffrey Modell Foundation
Due Dates: March 13, 2026 (Letter of Intent, Translational Research Program, Cycle 14) | July 24, 2026 (Full application, invited investigators)
Funding Amounts: Translational Research: up to $250,000 over 2 years; Specific Defect: up to $50,000 over 2 years; C.H.I.L.D.R.E.N!: up to $25,000/year (max 2 years); G.E.N.I.E.: varies
Summary: Supports translational research, discovery of immune defects, and physician education to advance the diagnosis, understanding, and treatment of Primary Immunodeficiency.
Key Information: LOI required for Translational Research Program; rolling deadlines for other programs.
The Jeffrey Modell Foundation's Research & Education Grants support innovative research and education initiatives aimed at improving the diagnosis, understanding, and treatment of Primary Immunodeficiency (PI). Funding is available for translational studies that bridge basic science and clinical applications, research into specific immune system defects, projects improving outcomes for children with PI, and physician education programs that foster global collaboration and early diagnosis. The Foundation encourages projects that address unmet needs, novel mechanisms, and patient-centered outcomes, with an emphasis on projects that would not advance without this support.